Cover Image
市場調查報告書

先進藥物遞輸系統 (DDS) :技術及全球市場

Global Markets and Technologies for Advanced Drug Delivery Systems

出版商 BCC Research 商品編碼 219299
出版日期 內容資訊 英文 196 Pages
訂單完成後即時交付
價格
Back to Top
先進藥物遞輸系統 (DDS) :技術及全球市場 Global Markets and Technologies for Advanced Drug Delivery Systems
出版日期: 2016年03月24日 內容資訊: 英文 196 Pages
簡介

全球先進藥物輸送市場規模,預計從2015年的1,788億美元到2020年達約2,273億美元,以4.9%的年複合成長率擴大。

本報告提供全球藥物輸送市場現狀與未來趨勢的相關調查,各終端用戶、應用領域的市場分析,包含市場資料、年複合成長率預測的市場趨勢分析,市場現狀,阻礙因素,創新,及未來的需求相關討論,藥物輸送的各分類的評估,法規環境、相關技術分析,及主要企業簡介等彙整,為您概述為以下內容。

第1章 簡介

第2章 摘要

第3章 概要

  • 先進藥物輸送市場發展、動態
  • 先進藥物輸送產業的生命階段/成長階段
  • 多公佈技術市場
  • 全球先進藥物輸送市場分析
  • 競爭情形
  • 專利分析

第4章 先進藥物輸送技術/系統市場

  • 先進短時間作用型技術
  • 放出調節藥物輸送
    • 標的導向藥物輸送技術
    • 長時間作用型
    • 持續性放出型、控制放出型 (徐放形式) 藥物遞輸系統
    • 延遲放出型、脈衝放出型藥物輸送技術

第5章 市場:各給藥途徑

  • 口服藥物輸送市場
  • 非口服/注射劑藥物輸送市場
  • 局部藥物輸送市場
  • 經皮藥物輸送市場
  • 經黏膜給藥市場
  • 植入藥物輸送市場

第6章 市場:各藥物輸送媒體/電信業者

  • 微脂體
    • 市場分析、未來展望
    • 樹狀聚合物膠束
    • 聚合物
  • 奈米載體、奈米粒子
  • 微小粒子/微球
  • 單株抗體
  • 前驅藥物
  • 其他

第7章 市場:各應用領域

  • 心血管
  • 腫瘤
  • 消化器官疾病
  • 泌尿系統
  • 糖尿病
  • 皮膚科
  • 中樞神經系統
  • 呼吸系統藥物遞輸系統
  • 發炎性疾病、過敏
  • 眼科
  • 病毒、細菌性疾病
  • 荷爾蒙替代療法、婦產科
  • 其他治療分類

第8章 競爭發展

  • 簡介

第9章 地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 其他 (ROW)

第10章 附錄

第11章 企業簡介

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PHM006K

REPORT HIGHLIGHTS

The global advanced drug delivery market should grow from roughly $178.8 billion in 2015 to nearly $227.3 billion by 2020, with a compound annual growth rate (CAGR) of 4.9%.

This report provides:

  • An overview of the global market for drug delivery systems, including the market as seen by end users of different applications
  • Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020
  • Discussion of the current state, setbacks, innovations, and the future needs of the market
  • Examination of the different categories of drug delivery, broken down by market shares of the leading manufacturers and/or suppliers, as well as acquisitions, mergers, and alliances by companies and global organizations
  • Analyses of the regulatory environment, and the technology involved, including the latest trends and developments
  • Profiles of major players in the industry

SCOPE OF REPORT

The report's scope includes the following:

  • Key market analysis
  • Market dynamics (drivers and restraints)
  • Market estimation for the forecasted period (2015 through 2020)
  • Competitive developments and landscape
  • Regional analysis
  • Profiles of key market players
  • Patents

ANALYST'S CREDENTIALS

Himani S. Wadhwa has more than five years of experience in healthcare, biotechnology and life sciences business research and consulting. She has commissioned several syndicated market and business reports in the life sciences domain, and has been tracking several healthcare sectors over the last seven years.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • SCOPE OF REPORT
  • INTENDED AUDIENCE
  • INFORMATION SOURCES AND METHODOLOGY
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - SUMMARY

  • SUMMARY TABLE: GLOBAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • SUMMARY FIGURE: GLOBAL ADVANCED DRUG DELIVERY MARKET BY REGION, 2014-2020 ($ MILLIONS)

CHAPTER 3 - OVERVIEW

  • ADVANCED DRUG DELIVERY MARKET EVOLUTION AND DYNAMICS
  • ADVANCED DRUG DELIVERY INDUSTRY LIFE/GROWTH STAGES
    • FIRST GENERATION - CONTROLLED/MODIFIED RELEASE TECHNOLOGIES
    • SECOND GENERATION - NEW WAVE OF ADVANCED DRUG DELIVERY TECHNOLOGIES WITH EMERGENCE OF SMART DRUG DELIVERY
    • THIRD GENERATION - NEW FRONTIER OF ADVANCED DRUG DELIVERY WITH SIGNIFICANT ADVANCES IN MODIFIED DELIVERY SYSTEMS
  • MULTIPLE-RELEASE TECHNOLOGY MARKET
    • FIXED DOSE COMBINATION MULTIPLE RELEASE TECHNOLOGY -- MAJOR PHASE OF NEXT GENERATION ADVANCED DRUG DELIVERY MARKET.
    • MARKET DRIVERS AND RESTRAINTS
  • GLOBAL ADVANCED DRUG DELIVERY MARKET ANALYSIS
    • FIGURE 1: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY MARKET BY REGION, 2015 (%)
    • FIGURE 2: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS, 2015 (%)
    • FIGURE 3: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS BY ROUTE OF ADMINISTRATION (2015) (%)
  • COMPETITIVE LANDSCAPE
  • PATENT ANALYSIS
    • FIGURE 4: PATENT ANALYSIS BY PATENT JURISDICTION, 2014-DECEMBER 2015 (%)

CHAPTER 4 - ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS MARKET

  • TABLE 1: GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • TABLE 2: GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
  • FIGURE 5: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY RELEASE TECHNOLOGIES/SYSTEMS, 2015 (%)
  • ADVANCED IMMEDIATE-RELEASE TECHNOLOGY
    • DRIVERS AND RESTRAINTS
      • TABLE 3 GLOBAL ADVANCED IMMEDIATE-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • MODIFIED DRUG DELIVERY
      • TABLE 4: GLOBAL MODIFIED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
      • TABLE 5: GLOBAL MODIFIED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TARGETED DRUG DELIVERY TECHNOLOGY
      • Drivers and Restraints
      • Market Analysis
      • Future Outlook
      • Market Players
        • TABLE 6: GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY DRUG DELIVERY VEHICLES, THROUGH 2020 ($ MILLIONS)
        • TABLE 7: GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
        • TABLE 8: GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • EXTENDED DRUG RELEASE
      • TABLE 9: GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY DRUG DELIVERY VEHICLE, THROUGH 2020 ($ MILLIONS)
      • TABLE 10: GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
      • TABLE 11: GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
      • TABLE 12: GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • SUSTAINED AND CONTROLLED RELEASE DRUG DELIVERY SYSTEMS
      • Drivers and Restraints
      • Market Analysis and Future Outlook
      • Market Players
        • TABLE 13: GLOBAL SUSTAINED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
        • TABLE 14: GLOBAL CONTROLLED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • DELAYED RELEASE AND PULSATILE RELEASE DRUG DELIVERY TECHNOLOGY
      • Market Analysis
      • Drivers and Restraints
      • Market Players
        • TABLE 15: GLOBAL DELAYED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
        • TABLE 16: GLOBAL PULSATILE-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

CHAPTER 5 - MARKET BY ROUTE OF ADMINISTRATION

  • TABLE 17: GLOBAL ADVANCED DRUG DELIVERY MARKET BY ROUTES OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
  • FIGURE 6: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS BY ROUTE OF ADMINISTRATION, 2015 (%)
  • ORAL DRUG DELIVERY MARKET
    • MARKET DRIVERS AND RESTRAINTS/CHALLENGES
    • MARKET ANALYSIS - INNOVATIONS, DEVELOPMENTS AND KEY COMPETITIVE FACTORS
      • TABLE 18: EXAMPLES OF ORAL FAST-DISSOLVED/DISINTEGRATED (FDTS) TECHNOLOGIES AND PRODUCTS
      • Opportunities/Future Outlook
    • MARKET PLAYERS
      • TABLE 19: GLOBAL ORAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • PARENTERAL/INJECTABLE DRUG DELIVERY MARKET
    • DRIVERS AND RESTRAINTS
    • MARKET ANALYSIS - INNOVATIONS, DEVELOPMENTS AND KEY COMPETITIVE FACTORS
    • FUTURE OUTLOOK/OPPORTUNITIES
    • MARKET PLAYERS
      • TABLE 20: GLOBAL INJECTABLE ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • TOPICAL DRUG DELIVERY MARKET
    • MARKET ANALYSIS - DEVELOPMENTS AND INNOVATIONS
    • MARKET DRIVERS AND RESTRAINTS
    • MARKET PLAYERS
      • TABLE 21: GLOBAL TOPICAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • TRANSDERMAL DRUG DELIVERY
    • MARKET DRIVERS AND RESTRAINTS
    • MARKET ANALYSIS - PRODUCT EXAMPLES, INNOVATION AND FUTURE OUTLOOK
    • FUTURE OUTLOOK/OPPORTUNITIES
    • MARKET PLAYERS
      • TABLE 22: GLOBAL TRANSDERMAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • TRANSMUCOSAL MARKET
    • MARKET DRIVERS AND RESTRAINTS
    • MARKET PLAYERS
      • TABLE 23: GLOBAL TRANSMUCOSAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
      • TABLE 24: GLOBAL TRANSMUCOSAL ADVANCED DRUG DELIVERY MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
    • NASAL AND PULMONARY MARKET
      • Market Drivers and Analysis
        • TABLE 25: GLOBAL TRANSMUCOSAL NASAL AND PULMONARY ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • OCULAR DRUG DELIVERY
      • Market Analysis
        • TABLE 26: GLOBAL TRANSMUCOSAL OCULAR ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • ORAL - BUCCAL DRUG DELIVERY
      • Market Analysis
        • TABLE 27: GLOBAL TRANSMUCOSAL ORAL BUCCAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • VAGINAL DRUG DELIVERY
      • TABLE 28: GLOBAL TRANSMUCOSAL VAGINAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • RECTAL DRUG DELIVERY
      • TABLE 29: GLOBAL TRANSMUCOSAL RECTAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • IMPLANTS DRUG DELIVERY
    • MARKET DRIVERS AND RESTRAINTS
    • MARKET ANALYSIS AND FUTURE OUTLOOK
    • MARKET PLAYERS
      • TABLE 30: GLOBAL IMPLANTS ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • CONTRACEPTIVE DEVICES
      • TABLE 31: GLOBAL CONTRACEPTIVE DEVICES FOR ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

CHAPTER 6 - MARKET BY DRUG DELIVERY VEHICLES/CARRIERS

  • TABLE 32 GLOBAL ADVANCED DRUG DELIVERY VEHICLES/CARRIERS MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
  • FIGURE 7: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, 2015 (%)
  • LIPOSOMES
    • MARKET ANALYSIS AND FUTURE OUTLOOK
      • TABLE 33: GLOBAL LIPOSOMES MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • POLYMERIC THERAPEUTICS
      • TABLE 34: GLOBAL POLYMERIC THERAPEUTICS MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
      • TABLE 35: GLOBAL POLYMERIC THERAPEUTICS MARKET IN ADVANCED DRUG DELIVERY BY TYPE, THROUGH 2020 ($ MILLIONS)
    • MICELLES AND DENDRIMERS
      • Polymeric Micelles (Micelles)
      • Market Analysis
        • TABLE 36: GLOBAL POLYMERIC MICELLES MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
      • Dendrimers
      • Market Analysis
        • TABLE 37: GLOBAL DENDRIMERS MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • POLYMERS (POLYMERIC DRUG DELIVERY)
      • Market Analysis
      • Reservoir-based Systems
      • Monolithic Matrix Systems
      • Polymer-drug Conjugate Systems
        • TABLE 38: GLOBAL POLYMERIC DRUGS MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
        • TABLE 39: GLOBAL POLYMERIC DRUGS MARKET IN ADVANCED DRUG DELIVERY BY TYPE OF DRUG SYSTEM, THROUGH 2020 ($ MILLIONS)
    • NANOCARRIERS/NANOPARTICLES
      • TABLE 40: GLOBAL NANOCARRIERS/NANOPARTICLES MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • MICROPARTICLES/MICROSPHERES
      • TABLE 41: GLOBAL MICROPARTICLES/MICROSPHERES MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • MONOCLONAL ANTIBODIES (MABS)
      • TABLE 42: GLOBAL MONOCLONAL ANTIBODIES MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • PRODRUGS
      • TABLE 43: GLOBAL PRODRUGS MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
      • TABLE 44: GLOBAL PRODRUGS MARKET IN ADVANCED DRUG DELIVERY BY TYPE, THROUGH 2020 ($ MILLIONS)
    • OTHERS
      • TABLE 45: GLOBAL OTHER DRUG DELIVERY VEHICLES/CARRIERS MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)

CHAPTER 7 - MARKET BY APPLICATIONS

  • TABLE 46: GLOBAL ADVANCED DRUG DELIVERY MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
  • FIGURE 8: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS BY APPLICATION, 2015 (%)
  • CARDIOVASCULAR
    • TABLE 47: GLOBAL ADVANCED DRUG DELIVERY CARDIOVASCULAR APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • ONCOLOGY MARKET
    • TABLE 48: GLOBAL ADVANCED DRUG DELIVERY ONCOLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • GASTROINTESTINAL DISORDERS
    • TABLE 49: GLOBAL ADVANCED DRUG DELIVERY GASTROINTESTINAL APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • UROLOGY
    • TABLE 50: GLOBAL ADVANCED DRUG DELIVERY UROLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • DIABETES
    • TABLE 51: GLOBAL ADVANCED DRUG DELIVERY DIABETES APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • DERMATOLOGY
    • TABLE 52: GLOBAL ADVANCED DRUG DELIVERY DERMATOLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • CENTRAL NERVOUS SYSTEM
    • TABLE 53: GLOBAL ADVANCED DRUG DELIVERY CENTRAL NERVOUS SYSTEM APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • RESPIRATORY DRUG DELIVERY SYSTEMS
    • TABLE 54: GLOBAL ADVANCED DRUG DELIVERY RESPIRATORY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • INFLAMMATORY DISEASES AND ALLERGIES
    • TABLE 55: GLOBAL ADVANCED DRUG DELIVERY INFLAMMATORY DISEASES AND ALLERGIES APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • OPHTHALMOLOGY
    • TABLE 56: GLOBAL ADVANCED DRUG DELIVERY OPHTHALMOLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • VIRAL AND BACTERIAL DISEASES
    • TABLE 57: GLOBAL ADVANCED DRUG DELIVERY VIRAL AND BACTERIAL DISEASES APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • HORMONE REPLACEMENT THERAPY AND GYNECOLOGY
    • TABLE 58: GLOBAL ADVANCED DRUG DELIVERY HORMONAL REPLACEMENT THERAPY AND GYNECOLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • OTHER THERAPEUTIC CATEGORIES
    • TABLE 59: GLOBAL ADVANCED DRUG DELIVERY OTHER THERAPEUTIC APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

CHAPTER 8 - COMPETITIVE DEVELOPMENTS

  • INTRODUCTION
    • FIGURE 9: DEVELOPMENTS IN GLOBAL PATIENT MONITORING DEVICES MARKET, 2013-DECEMBER 2015 (%)
    • TABLE 60: DEVELOPMENTS - PRODUCT LAUNCH/APPROVAL/UPDATE, 2013- DEC 2015
    • TABLE 61: DEVELOPMENTS -- COLLABORATIONS/PARTNERSHIPS/AGREEMENTS, 2013- DEC 2015
    • TABLE 62: DEVELOPMENTS - ACQUISITIONS AND MERGERS, 2013- DEC 2015
    • TABLE 63: DEVELOPMENTS - MISCELLANEOUS, 2013- OCT 2015

CHAPTER 9 - REGIONAL ANALYSIS

  • NORTH AMERICA
    • TABLE 64: NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • TABLE 65: NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 66: NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 67: NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS)
  • EUROPE
    • TABLE 68: EUROPEAN ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • TABLE 69: EUROPEAN ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 70: EUROPEAN ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS, THROUGH 2020 ($ MILLIONS)
    • TABLE 71: EUROPEAN ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS)
  • ASIA-PACIFIC
    • TABLE 72: ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • TABLE 73: ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 74: ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS, THROUGH 2020 ($ MILLIONS)
    • TABLE 75: ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS)
  • REST OF THE WORLD (ROW)
    • TABLE 76: ROW ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • TABLE 77: ROW ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 78: ROW ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS, THROUGH 2020 ($ MILLIONS)
    • TABLE 79: ROW ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS)

CHAPTER 10 APPENDIX

  • TABLE 80: LIST (EXAMPLES) OF PATENTS, 2015
  • TABLE 81: LIST (EXAMPLES) PATENTS, 2014

CHAPTER 11 - COMPANY PROFILES

  • 3M COMPANY
  • ABBOTT LABORATORIES
  • ALLERGAN PLC
  • AKELA PHARMA INC.
  • ALCON INC. (NOVARTIS COMPANY)
  • AMGEN INC.
  • A.P. PHARMA/ HERON THERAPEUTICS, INC.
  • APTALIS PHARMA INC. /ADARE PHARMACEUTICALS
  • ALKERMES
  • ASTELLAS PHARMA INC.
  • ASTRAZENECA PLC
  • BAUSCH & LOMB
  • BAXTER INTERNATIONAL INC.
  • BAYER HEALTHCARE PHARMACEUTICALS
  • BIOGEN IDEC
  • BIOSANTE PHARMACEUTICALS INC.
  • BOEHRINGER INGELHEIM
  • BOSTON SCIENTIFIC
  • BRISTOL-MYERS SQUIBB
  • CAPSUGEL
  • CATALENT
  • CELGENE CORP.
  • EISAI CO. LTD.
  • ELAN DRUG TECHNOLOGIES/PERRIGO COMPANY
  • ENZON PHARMACEUTICALS
  • ELIXIR MEDICAL CORP.
  • FLAMEL TECHNOLOGIES
  • GENENTECH INC.
  • GENEREX BIOTECHNOLOGY CORP.
  • GENZYME CORP.
  • GILEAD SCIENCES INC.
  • GLAXOSMITHKLINE PLC
  • HISAMITSU PHARMACEUTICAL CO. INC.
  • ELI LILLY & IMCLONE SYSTEMS
  • JANSSEN BIOTECH INC.
  • JOHNSON & JOHNSON
  • KEMPHARM INC.
  • KYOTO MEDICAL PLANNING CO. LTD.
  • MANNKIND CORP.
  • MEDTRONIC
  • MERCK & CO.
  • MYLAN LABORATORIES INC.
  • NEKTAR THERAPEUTICS
  • NEWGEN BIOPHARMA
  • NOVARTIS AG
  • NOVAVAX INC.
  • NOVEN PHARMACEUTICALS INC.
  • PAR PHARMACEUTICAL COMPANIES INC.
  • PDL BIOPHARMA INC.
  • PFIZER INC.
  • ROCHE HOLDING AG
  • SANOFI SA
  • SKYEPHARMA
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • THERAJECT INC.
  • VALEANT PHARMACEUTICALS INTERNATIONAL INC.
  • XEL PHARMACEUTICALS INC.

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 1: GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 2: GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 3: GLOBAL ADVANCED IMMEDIATE-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 4: GLOBAL MODIFIED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 5: GLOBAL MODIFIED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 6: GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY DRUG DELIVERY VEHICLES, THROUGH 2020 ($ MILLIONS)
    • TABLE 7: GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 8: GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 9: GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY DRUG DELIVERY VEHICLE, THROUGH 2020 ($ MILLIONS)
    • TABLE 10: GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 11: GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 12: GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 13: GLOBAL SUSTAINED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 14: GLOBAL CONTROLLED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 15: GLOBAL DELAYED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 16: GLOBAL PULSATILE-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 17: GLOBAL ADVANCED DRUG DELIVERY MARKET BY ROUTES OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 18: EXAMPLES OF ORAL FAST-DISSOLVED/DISINTEGRATED (FDTS) TECHNOLOGIES AND PRODUCTS
    • TABLE 19: GLOBAL ORAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 20: GLOBAL INJECTABLE ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 21: GLOBAL TOPICAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 22: GLOBAL TRANSDERMAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 23: GLOBAL TRANSMUCOSAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 24: GLOBAL TRANSMUCOSAL ADVANCED DRUG DELIVERY MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 25: GLOBAL TRANSMUCOSAL NASAL AND PULMONARY ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 26: GLOBAL TRANSMUCOSAL OCULAR ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 27: GLOBAL TRANSMUCOSAL ORAL BUCCAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 28: GLOBAL TRANSMUCOSAL VAGINAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 29: GLOBAL TRANSMUCOSAL RECTAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 30: GLOBAL IMPLANTS ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 31: GLOBAL CONTRACEPTIVE DEVICES FOR ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 32: GLOBAL ADVANCED DRUG DELIVERY VEHICLES/CARRIERS MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 33: GLOBAL LIPOSOMES MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 34: GLOBAL POLYMERIC THERAPEUTICS MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 35: GLOBAL POLYMERIC THERAPEUTICS MARKET IN ADVANCED DRUG DELIVERY BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 36: GLOBAL POLYMERIC MICELLES MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 37: GLOBAL DENDRIMERS MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 38: GLOBAL POLYMERIC DRUGS MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 39: GLOBAL POLYMERIC DRUGS MARKET IN ADVANCED DRUG DELIVERY BY TYPE OF DRUG SYSTEM, THROUGH 2020 ($ MILLIONS)
    • TABLE 40: GLOBAL NANOCARRIERS/NANOPARTICLES MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 41: GLOBAL MICROPARTICLES/MICROSPHERES MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 42: GLOBAL MONOCLONAL ANTIBODIES MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 43: GLOBAL PRODRUGS MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 44: GLOBAL PRODRUGS MARKET IN ADVANCED DRUG DELIVERY BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 45: GLOBAL OTHER DRUG DELIVERY VEHICLES/CARRIERS MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 46: GLOBAL ADVANCED DRUG DELIVERY MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 47: GLOBAL ADVANCED DRUG DELIVERY CARDIOVASCULAR APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 48: GLOBAL ADVANCED DRUG DELIVERY ONCOLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 49: GLOBAL ADVANCED DRUG DELIVERY GASTROINTESTINAL APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 50: GLOBAL ADVANCED DRUG DELIVERY UROLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 51: GLOBAL ADVANCED DRUG DELIVERY DIABETES APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 52: GLOBAL ADVANCED DRUG DELIVERY DERMATOLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 53: GLOBAL ADVANCED DRUG DELIVERY CENTRAL NERVOUS SYSTEM APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 54: GLOBAL ADVANCED DRUG DELIVERY RESPIRATORY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 55: GLOBAL ADVANCED DRUG DELIVERY INFLAMMATORY DISEASES AND ALLERGIES APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 56: GLOBAL ADVANCED DRUG DELIVERY OPHTHALMOLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 57: GLOBAL ADVANCED DRUG DELIVERY VIRAL AND BACTERIAL DISEASES APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 58: GLOBAL ADVANCED DRUG DELIVERY HORMONAL REPLACEMENT THERAPY AND GYNECOLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 59: GLOBAL ADVANCED DRUG DELIVERY OTHER THERAPEUTIC APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 60: DEVELOPMENTS - PRODUCT LAUNCH/APPROVAL/UPDATE, 2013- DEC 2015
    • TABLE 61: DEVELOPMENTS -- COLLABORATIONS/PARTNERSHIPS/AGREEMENTS, 2013- DEC 2015
    • TABLE 62: DEVELOPMENTS - ACQUISITIONS AND MERGERS, 2013- DEC 2015
    • TABLE 63: DEVELOPMENTS - MISCELLANEOUS, 2013- OCT 2015
    • TABLE 64: NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • TABLE 65: NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 66: NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 67: NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS)
    • TABLE 68: EUROPEAN ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • TABLE 69: EUROPEAN ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 70: EUROPEAN ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS, THROUGH 2020 ($ MILLIONS)
    • TABLE 71: EUROPEAN ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS)
    • TABLE 72: ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • TABLE 73: ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 74: ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS, THROUGH 2020 ($ MILLIONS)
    • TABLE 75: ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS)
    • TABLE 76: ROW ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • TABLE 77: ROW ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 78: ROW ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS, THROUGH 2020 ($ MILLIONS)
    • TABLE 79: ROW ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS)
    • TABLE 80: LIST (EXAMPLES) OF PATENTS, 2015
    • TABLE 81: LIST (EXAMPLES) PATENTS, 2014

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL ADVANCED DRUG DELIVERY MARKET BY REGION, 2014-2020 ($ MILLIONS)
    • FIGURE 1: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY MARKET BY REGION, 2015 (%)
    • FIGURE 2: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS, 2015 (%)
    • FIGURE 3: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS BY ROUTE OF ADMINISTRATION (2015) (%)
    • FIGURE 4: PATENT ANALYSIS BY PATENT JURISDICTION, 2014-DECEMBER 2015 (%)
    • FIGURE 5: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY RELEASE TECHNOLOGIES/SYSTEMS, 2015 (%)
    • FIGURE 6: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS BY ROUTE OF ADMINISTRATION, 2015 (%)
    • FIGURE 7: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, 2015 (%)
    • FIGURE 8: MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS BY APPLICATION, 2015 (%)
    • FIGURE 9: DEVELOPMENTS IN GLOBAL PATIENT MONITORING DEVICES MARKET, 2013-DECEMBER 2015 (%)
Back to Top